Home > Insider Trading > Filing (0001567619-19-021788)

Filing Details

Accession Number:: 0001567619-19-021788
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2019-11-18 18:02:36
Reporting Period:: 2019-11-18

Accepted Time:: 2019-11-18 18:02:36
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
722723	Hanger Inc.	HNGR	Services-Specialty Outpatient Facilities, Nec (8093)	840904275

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1745679	C Jay Wendt	10910 Domain Drive, Suite 300 Austin TX 78758	President, Products & Services	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2019-11-18	19,825	$12.77	55,077	No	4	M	Direct
Common Stock	Disposition	2019-11-18	4,825	$23.87	50,252	No	4	S	Direct
Common Stock	Disposition	2019-11-18	5,000	$23.92	45,252	No	4	S	Direct
Common Stock	Disposition	2019-11-18	5,000	$23.95	40,252	No	4	S	Direct
Common Stock	Disposition	2019-11-18	5,000	$24.00	35,252	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Options (right to buy)	Disposition	2019-11-18	19,825	$0.00	19,825	$12.77

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
9,913		2027-05-19	No	4	M	Direct

Reported Derivative Holdings

Show Other Fields >>

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Performance Share Units	$0.00		2020-05-19	11,895	11,895	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2020-05-19	11,895	11,895	Direct

Footnotes

The price in Column 4 is a weighted average price. The prices actually received ranged from $23.8501 to $23.95. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price.
The price in Column 4 is a weighted average price. The prices actually received ranged from $23.88 to $23.995 The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price.
The price in Column 4 is a weighted average price. The prices actually received ranged from $23.86 to $23.9996. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price.
Includes (i) unvested restricted shares totaling 5,220 shares of stock from an initial grant of 5,220 shares of restricted stock which begin to vest on March 8, 2020; (ii) unvested restricted shares and fully vested shares totaling 2,867 shares of stock from an initial grant of 3,163 shares of restricted stock which begins to vest on March 9, 2019; (iii) unvested and vested restricted shares totaling 3,604 shares of stock from an initial grant of 3,975 shares of restricted stock made on March 9, 2018; (iv) unvested restricted shares and fully vested shares totaling 5,804 shares of stock from an initial grant of 7,688 shares of restricted stock and performance shares made on March 8, 2017 (v) unvested restricted shares and fully vested shares totaling 2,300 shares of stock from an initial grant of 3,000 shares of restricted stock made on October 11, 2016; [continued in next footnote]
(vi) unvested restricted shares and fully vested shares totaling 2,077 shares of stock from an initial grant of 3,700 shares of restricted stock made on April 29, 2016; (vii) fully vested shares totaling 2,350 shares of stock from an initial grant of 3,305 shares of restricted stock made on November 10, 2015; (viii) fully vested shares totaling 5,912 shares of stock from an initial grant of 8,480 shares of restricted stock and performance shares made on March 6, 2015; (ix) fully vested shares totaling 1,052 shares of stock from an initial grant of 1,997 shares of restricted stock made on March 7, 2014; [continued in next footnote]
(x) fully vested shares totaling 2,416 shares of stock from an initial grant of 3,958 shares of restricted stock and performance shares made on March 11, 2013 and (xi) fully vested shares totaling 1,650 shares of stock from an initial grant of 6,600 shares of restricted stock and performance shares made on March 7, 2012.
Except as otherwise noted, all remaining unvested restricted shares will continue to vest at a rate of 25% per year of the original grant amount on the anniversary date of the grant.
Stock options were granted under the Company's Special Equity Plan and vest 1/3 on each of May 19, 2018, 2019 and 2020.
Performance share units ("PSUs") were granted under the Company's Special Equity Plan. Each PSU represents a contingent right to receive one share of common stock if predetermined levels of absolute common stock price compounded annual growth rate are achieved over a three-year performance period ending on the third anniversary of the grant date. The number of PSUs shown in the table represents the maximum number that could be earned; the target number is one-half the maximum number.